title: CFTR is required for cellular entry and internalization of Chlamydia trachomatis.
abstract: Chlamydia trachomatis is an obligate intracellular Gram-negative pathogen affecting over 600 million people worldwide with 92 million new cases occurring globally each year. C. trachomatis enter the cells and replicate to infect different tissues/organs, giving rise to a spectrum of pathological conditions; however, the exact mechanism or receptor(s) for their entry is not well understood. Here we report that CFTR (cystic fibrosis transmembrane conductance regulator), an apical epithelial anion channel, is required for cellular entry and internalization of C. trachomatis. Human epithelial cell lines expressing functional CFTR internalized more C. trachomatis than the cells expressing mutant Delta508 CFTR. The in vitro cellular uptake of C. trachomatis can be blocked by CFTR inhibitors or antibody, and the in vivo cellular uptake of C. trachomatis in CFTR mutant (CFTR(-/-)) mice was significantly less compared with that in the wild-type. Direct interaction between CFTR and C. trachomatis LPS (lipopolysaccharide) is demonstrated by their immune-co-localization and co-immunoprecipitation. Despite an increase in CFTR expression observed upon C. trachomatis LPS challenge, a reduction in its ion channel activity is observed, consistent with the notion that CFTR functions as a receptor for cellular entry and internationization of C. trachomatis, with compromised ion-channel function. These findings, for the first time, demonstrate that CFTR functions as a cell-surface receptor for epithelial cell entry, and internalization of C. trachomatis and these findings may lead to the development of new treatment strategies to curtail the spread of chlamydial infections.
authors.affiliation: Epithelial Cell Biology Research Center, Department of Physiology, The Chinese University of Hong Kong, Shatin, NT, Hong Kong SAR, People's Republic of China.
authors.forename: Louis Chukwuemeka
authors.initials: LC
authors.lastname: Ajonuma
authors.forename: Kin Lam
authors.initials: KL
authors.lastname: Fok
authors.forename: Lok Sze
authors.initials: LS
authors.lastname: Ho
authors.forename: Paul Kay Sheung
authors.initials: PK
authors.lastname: Chan
authors.forename: Pak H
authors.initials: PH
authors.lastname: Chow
authors.forename: Lai Ling
authors.initials: LL
authors.lastname: Tsang
authors.forename: Connie Hau Yan
authors.initials: CH
authors.lastname: Wong
authors.forename: Jie
authors.initials: J
authors.lastname: Chen
authors.forename: Shen
authors.initials: S
authors.lastname: Li
authors.forename: Dewi Kenneth
authors.initials: DK
authors.lastname: Rowlands
authors.forename: Yiu Wa
authors.initials: YW
authors.lastname: Chung
authors.forename: Hsiao Chang
authors.initials: HC
authors.lastname: Chan
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D002460:Cell Line; D002690:Chlamydia Infections / Q000378:metabolism / Q000382:microbiology*; D002692:Chlamydia trachomatis / Q000378:metabolism*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D004847:Epithelial Cells / Q000378:metabolism / Q000382:microbiology / Q000648:ultrastructure; D006367:HeLa Cells; D006801:Humans; D047468:Immunoprecipitation; D008070:Lipopolysaccharides / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D009154:Mutation
chemical_list: D000911:Antibodies, Monoclonal; D008070:Lipopolysaccharides; D019005:Cystic Fibrosis Transmembrane Conductance Regulator